Dental Care Clinics in Wauwatosa, WI Accepting Medicare
30 Dental Care Clinics found. Showing 21 - 30
 Dental Castle Inc Dentist Medicare: Not Enrolled in Medicare Practice Location: 2669 N Swan Blvd, Wauwatosa, WI 53226 Phone: 414-258-2216 Fax: 414-258-9466 |
Brian J. Blocher Dds Sc Dentist - Oral and Maxillofacial Surgery Medicare: Not Enrolled in Medicare Practice Location: 201 N Mayfair Rd Ste 520, Wauwatosa, WI 53226 Phone: 414-607-0222 Fax: 414-607-0220 |
Highland Park Family Dentistry, Sc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 6101 W Vliet St, Wauwatosa, WI 53213 Phone: 414-475-9035 Fax: 414-475-9039 |
Neu Family Dentistry, S.c. Dentist Medicare: Not Enrolled in Medicare Practice Location: 2600 N Mayfair Rd, Suite 450, Wauwatosa, WI 53226 Phone: 414-258-8444 Fax: 414-258-9121 |
Harris Family Dental, Sc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2600 N Mayfair Rd, Ste 690, Wauwatosa, WI 53226 Phone: 414-771-1228 Fax: 414-476-2515 |
Wauwatosa Family Dental Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 11904 W North Ave Ste 105, Wauwatosa, WI 53226 Phone: 414-454-0700 Fax: 414-778-0705 |
Drs. Marinelli & Ferentchak Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1011 N Mayfair Rd, Suite 303, Wauwatosa, WI 53226 Phone: 414-771-4480 Fax: 414-771-8862 |
Huck Dental Llc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 10625 W North Ave, Suite 320, Wauwatosa, WI 53226 Phone: 414-774-5020 |
Wisconsin Endodontic Group, S.c. Dentist - Endodontics Medicare: Not Enrolled in Medicare Practice Location: 2600 N. Mayfair Rd., Ste 240, Wauwatosa, WI 53226 Phone: 414-258-1500 Fax: 414-258-9353 |
Barton & Shaw Periodontics Dentist - Periodontics Medicare: Not Enrolled in Medicare Practice Location: 2600 N Mayfair Rd, Ste 340, Wauwatosa, WI 53226 Phone: 414-259-0660 Fax: 414-259-0819 |
News Archive
Opexa Therapeutics' endeavor in the field of stem cell technology
Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing Tovaxin®, a personalized T-cell immunotherapy for multiple sclerosis (MS), today announced that it has achieved its first technology transfer milestone in connection with the company's recently announced exclusive stem cell agreement with Novartis, one of the world's largest healthcare companies. The milestone was completed on schedule and triggers a payment of $500,000 to Opexa.
OptiNose reports positive results from study of fluticasone delivered by novel device in refractory CRS
Today OptiNose Inc. announced the positive results of a study evaluating the efficacy of fluticasone when delivered by the Company's novel bi-directional technology in patients with refractory chronic rhinosinusitis (CRS). The results of the study have been published in an article in the September issue of Rhinology.
Exploring how absence of ASS1 protein affects sick children may provide a 'lens' on cancer
What can a rare genetic childhood disease teach us about cancer? Dr. Ayelet Erez of the Weizmann Institute of Science's Department of Biological Regulation says: "A single-mutation disease can act as a 'lens.' If we find exactly what malfunctions in the sick child, we can zoom in and understand the role of the same gene among the many genetic changes that accompany cancer."
Study shows inhibition of transgelin prevents vasculogenic mimicry in breast cancer
An article published in Experimental Biology and Medicine identifies a new signaling pathway involved in breast cancer cell growth. The study, led by Dr. Chan-Wha Kim, from the Department of Biotechnology at Korea University in Seoul, reports that inhibition of the actin-binding protein transgelin prevents vasculogenic mimicry (VM), a process that provides tumor cells with the nutrients required for growth.
› Verified 1 days ago
- 1
- 2(current)